Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography

References

• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045–51.
   PubMed Web of Science ®Google Scholar
• Li JJ, Zhang YP, Yang P, Zeng HS, Qian XW, Zhang CY, et al. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina. Coron Artery Dis. 2008;19:293–7.
   PubMed Web of Science ®Google Scholar
• Kim J, Song TJ, Park JH, Lee HS, Nam CM, Nam HS, et al. Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. Atherosclerosis. 2012;222:464–7.
   PubMed Web of Science ®Google Scholar
• Ates AH, Canpolat U, Yorgun H, Kaya EB, Sunman H, Demiri E, et al. Total white blood cell count is associated with the presence, severity and extent of coronary atherosclerosis detected by dual-source multislice computed tomographic coronary angiography. Cardiol J. 2011;18:371–7.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost. 2009;7:328–31.
   PubMed Web of Science ®Google Scholar
• Tardif JC, Gregoire J, L'Allier PL, Ibrahim R, Lesperance J, Heinonen TM, et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA. 2007;297:1675–82.
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28:2071–7.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46:1619–25.
   PubMed Web of Science ®Google Scholar
• Canpolat U, Aytemir K, Yorgun H, Sahiner L, Kaya EB, Cay S, et al. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace. 2015;17:1807--15.
   PubMed Web of Science ®Google Scholar
• Kundi H, Gok M, Kiziltunc E, Cetin M, Cicekcioglu H, Cetin ZG, et al. Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia. Am J Cardiol. 2015;116:1685–9.
   PubMed Web of Science ®Google Scholar
• Karatas MB, Canga Y, Ozcan KS, Ipek G, Gungor B, Onuk T, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016;34:240–4.
   PubMed Web of Science ®Google Scholar
• Cetin EH, Cetin MS, Canpolat U, Aydin S, Topaloglu S, Aras D, et al. Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med. 2015;9:967–77.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li S, Zhu CG, Guo YL, Wu NQ, Xu RX, et al. Risk factors, coronary severity, outcome and ABO blood group: a Large Chinese Han Cohort Study. Medicine (Baltimore). 2015;94:e1708.
   PubMed Web of Science ®Google Scholar
• Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606.
   PubMed Web of Science ®Google Scholar
• Li JJ, Li S, Zhang Y, Xu RX, Guo YL, Zhu CG, et al. Proprotein convertase subtilisin/kexin type 9, C-reactive protein, coronary severity, and outcomes in patients with stable coronary artery disease: a Prospective Observational Cohort Study. Medicine (Baltimore). 2015;94:e2426.
   PubMed Web of Science ®Google Scholar
• Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb. 2003;10:63–71.
   PubMedGoogle Scholar
• Yang RH, Liu YF, Wang XJ, Liang JG, Liu JC. Correlation between high density lipoprotein and monocyte subpopulations among stable coronary atherosclerotic heart disease patients. Int J Clin Exp Med. 2015;8:16969–77.
   PubMed Web of Science ®Google Scholar
• Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008;18:228–32.
   PubMed Web of Science ®Google Scholar
• Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010;7:77–86.
   PubMed Web of Science ®Google Scholar
• Palmerini T, Coller BS, Cervi V, Tomasi L, Marzocchi A, Marrozzini C, et al. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. J Am Coll Cardiol. 2004;44:1570–7.
   PubMed Web of Science ®Google Scholar
• Glezeva N, Horgan S, Baugh JA. Monocyte and macrophage subsets along the continuum to heart failure: misguided heroes or targetable villains? J Mol Cell Cardiol. 2015;89:136--45.
   PubMed Web of Science ®Google Scholar
• Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003;108:2751–6.
   PubMed Web of Science ®Google Scholar